公开(公告)号：US20210353583A1

公开(公告)日：2021-11-18

申请号：US17319496

申请日：2021-05-13

申请人： Probioticsmart, LLC

发明人： Daniel J. DuBourdieu ,  Rajiv Lall

IPC分类号： A61K31/315 ,  C07F3/06 ,  A61K31/353 ,  A61K31/192 ,  A61K31/198 ,  A61K35/748 ,  A61K33/04 ,  A61K31/385 ,  A61K31/716 ,  A61K31/7008 ,  A61P37/06 ,  A61P39/06 ,  A61P3/02 ,  A23L33/00 ,  A23L33/105 ,  A23L33/16 ,  A23K20/111 ,  A23K10/16 ,  A23K20/20 ,  A23K50/75

摘要： The invention is directed to tetrahydrocurcuminoid-metal complexes. The complexes can be included in compositions that further include additional nutraceutical antimicrobials, antioxidants, and immune boosters. The tetrahydrocurcuminoid-metal complexes can be administered to animals to increase animal health, reduce stress, reduce oxidative stress, maintain health, improve health, improve immunity, improve vaccination efficacy, increase feed conversion rate, decrease pro-inflammatory cytokine levels, or any combination thereof in an animal. The tetrahydrocurcuminoid-metal complexes of the invention exhibit enhanced bioavailability relative to the individual, non-complexed components.

公开(公告)号：US20240325337A1

公开(公告)日：2024-10-03

申请号：US18654403

申请日：2024-05-03

申请人： Probioticsmart, LLC

发明人： Daniel J. DuBourdieu ,  Rajiv Lall

IPC分类号： A61K31/315 ,  A23K10/16 ,  A23K20/111 ,  A23K20/20 ,  A23K50/75 ,  A23L33/00 ,  A23L33/105 ,  A23L33/16 ,  A61K31/192 ,  A61K31/198 ,  A61K31/353 ,  A61K31/385 ,  A61K31/7008 ,  A61K31/716 ,  A61K33/04 ,  A61K35/748 ,  A61P3/02 ,  A61P37/06 ,  A61P39/06 ,  C07F3/06

CPC分类号： A61K31/315 ,  A23K10/16 ,  A23K20/111 ,  A23K20/30 ,  A23K50/75 ,  A23L33/105 ,  A23L33/16 ,  A23L33/40 ,  A61K31/192 ,  A61K31/198 ,  A61K31/353 ,  A61K31/385 ,  A61K31/7008 ,  A61K31/716 ,  A61K33/04 ,  A61K35/748 ,  A61P3/02 ,  A61P37/06 ,  A61P39/06 ,  C07F3/06 ,  A23V2002/00

摘要： The invention is directed to tetrahydrocurcuminoid-metal complexes. The complexes can be included in compositions that further include additional nutraceutical antimicrobials, antioxidants, and immune boosters. The tetrahydrocurcuminoid-metal complexes can be administered to animals to increase animal health, reduce stress, reduce oxidative stress, maintain health, improve health, improve immunity, improve vaccination efficacy, increase feed conversion rate, decrease pro-inflammatory cytokine levels, or any combination thereof in an animal. The tetrahydrocurcuminoid-metal complexes of the invention exhibit enhanced bioavailability relative to the individual, non-complexed components.